1 |
Mansour A, Mahmoud MY, Bakr AF, Ghoniem MG, Adam FA, El-Sherbiny IM. Fortified anti-proliferative activity of niclosamide for breast cancer treatment: In-vitro and in-vivo assessment. Life Sci 2023;316:121379. [PMID: 36623765 DOI: 10.1016/j.lfs.2023.121379] [Reference Citation Analysis]
|
2 |
Hu Z, Wang G, Zhao S, Jiang S, Hu J, Reheman A. Sustained release properties of liquid crystal functionalized poly (amino acid)s nanoparticles. Journal of Molecular Liquids 2022. [DOI: 10.1016/j.molliq.2022.120891] [Reference Citation Analysis]
|
3 |
Karami A, Fakhri S, Kooshki L, Khan H. Polydatin: Pharmacological Mechanisms, Therapeutic Targets, Biological Activities, and Health Benefits. Molecules 2022;27:6474. [PMID: 36235012 DOI: 10.3390/molecules27196474] [Reference Citation Analysis]
|
4 |
Tuli HS, Joshi R, Kaur G, Garg VK, Sak K, Varol M, Kaur J, Alharbi SA, Alahmadi TA, Aggarwal D, Dhama K, Jaswal VS, Mittal S, Sethi G. Metal nanoparticles in cancer: from synthesis and metabolism to cellular interactions. J Nanostruct Chem. [DOI: 10.1007/s40097-022-00504-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Liu M, Li Y, Kong B, Zhang G, Zhang Q. Polydatin down-regulates the phosphorylation level of STAT3 and induces pyroptosis in triple-negative breast cancer mice with a high-fat diet. Ann Transl Med 2022;10:173. [PMID: 35280371 DOI: 10.21037/atm-22-73] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|